Press "Enter" to skip to content

New patent for Amgen Inc drug CORLANOR

0
Copyright © DrugPatentWatch. Originally published at New patent for Amgen Inc drug CORLANOR

Annual Drug Patent Expirations for CORLANOR
Annual Drug Patent Expirations for CORLANOR

Corlanor is a drug marketed by Amgen Inc and is included in one NDA. It is available from one supplier. There are four patents protecting this drug.

CORLANOR drug price trends.

This drug has ninety-one patent family members in forty-two countries.

The generic ingredient in CORLANOR is ivabradine hydrochloride. One supplier is listed for this compound. Additional details are available on the ivabradine hydrochloride profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Copyright © DrugPatentWatch. Originally published at New patent for Amgen Inc drug CORLANOR
    Do NOT follow this link or you will be banned from the site!